
Optimizing JAK Inhibitor Use for Hemoglobin and Platelet Regulation in Myelofibrosis (Part 2)
Part 1 previously appeared in the April issue. Aaron T. Gerds, MD, MS: How do you interpret and apply COMFORT-I [NCT00952289] and COMFORT-II [NCT00934544] trial data across different patient subgroups when making treatment decisions? Prithviraj Bose, MD: …